Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trial

Abstract

BACKGROUND Although the use of bortezomib alone and in combination with steroids has shown efficacy in AL amyloidosis, its role in combination with high-dose melphalan and autologous stem cell transplantation (HDM/SCT) is unknown. In this study, we evaluated bortezomib in combination with dexamethasone (BD) for induction chemotherapy prior to HDM/SCT… (More)
DOI: 10.1186/1741-7015-12-2

Topics

8 Figures and Tables

Cite this paper

@inproceedings{Huang2014InductionTW, title={Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trial}, author={Xianghua Huang and Qing-Wen Wang and Wencui Chen and Cai-hong Zeng and Zhaohong Chen and Dehua Gong and Haitao Zhang and Zhihong Liu}, booktitle={BMC medicine}, year={2014} }